Evidence map›Paper›PMID 23015766›Full record

ArticleMarine drugs2012

Trypanocidal action of (-)-elatol involves an oxidative stress triggered by mitochondria dysfunction.

Vânia Cristina Desoti, Danielle Lazarin-Bidóia, Daniela Bueno Sudatti, Renato Crespo Pereira, Antonio Alonso, Tania Ueda-Nakamura, Benedito Prado Dias Filho, Celso Vataru Nakamura, Sueli De Oliveira Silva

Open access · goldAbstract read
In one paragraph

Article in Marine drugs, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 52 citations in OpenAlex.

  1. Marine drugs · 2026
    Review
  2. Article
  3. Review
  4. Parasitology · 2021
    Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Target-Based Screening against eIF4A1 Reveals the Marine Natural Product Elatol as a Novel Inhibitor of Translation Initiation withClinical cancer research : an official journal of the American Association for Cancer Research · 2018
    Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Vânia Cristina DesotiPostgraduate Program in Pharmaceutical Sciences, State University of Maringa, Colombo Avenue 5790, CEP 87020-900, Maringa, Parana, Brazil.
Danielle Lazarin-BidóiaPostgraduate Program in Pharmaceutical Sciences, State University of Maringa, Colombo Avenue 5790, CEP 87020-900, Maringa, Parana, Brazil.
Daniela Bueno SudattiDepartment of Marine Biology, Federal Fluminense University, PO Box 100644, CEP 24001-970, Niteroi, Rio de Janeiro, Brazil.
Renato Crespo PereiraDepartment of Marine Biology, Federal Fluminense University, PO Box 100644, CEP 24001-970, Niteroi, Rio de Janeiro, Brazil.
Antonio AlonsoInstitute of Physics, Federal University of Goias, CEP 74001-970, Goiania, Goias, Brazil.
Tania Ueda-NakamuraPostgraduate Program in Pharmaceutical Sciences, State University of Maringa, Colombo Avenue 5790, CEP 87020-900, Maringa, Parana, Brazil.
Benedito Prado Dias FilhoPostgraduate Program in Pharmaceutical Sciences, State University of Maringa, Colombo Avenue 5790, CEP 87020-900, Maringa, Parana, Brazil.
Celso Vataru NakamuraPostgraduate Program in Pharmaceutical Sciences, State University of Maringa, Colombo Avenue 5790, CEP 87020-900, Maringa, Parana, Brazil.
Sueli De Oliveira SilvaPostgraduate Program in Pharmaceutical Sciences, State University of Maringa, Colombo Avenue 5790, CEP 87020-900, Maringa, Parana, Brazil.
Universidade Estadual de Maringá · BRUniversidade Federal Fluminense · BRUniversidade Federal de Goiás · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Natural compounds have shown good potential for the discovery of new chemotherapeutics for the treatment of Chagas' disease. Recently, our group reported the effective trypanocidal activity of (-)-elatol, extracted from the red macroalgae Laurencia dendroidea present in the Brazilian coast against Trypanosoma cruzi. However, the mechanism of action of this compound has remained unclear. There are only hypotheses concerning its action on mitochondrial function. Here, we further investigated the mechanisms of action of (-)-elatol on trypomastigotes of T. cruzi. For this, we evaluated some biochemical alterations in trypomastigotes treated with (-)-elatol. Our results show that (-)-elatol induced depolarization of the mitochondrial membrane, an increase in the formation of mitochondrial superoxide anion and loss of cell membrane and DNA integrity. Additionally, (-)-elatol induced formation of autophagic vacuoles and a decrease in cell volume. All together, these results suggest that the trypanocidal action of (-)-elatol involves multiple events and mitochondria might be the initial target organelle. Our hypothesis is that the mitochondrial dysfunction leads to an increase of ROS production through the electron transport chain, which affects cell membrane and DNA integrity leading to different types of parasite death.

Indexed as

AutophagyBrazilCell MembraneCell SizeChagas DiseaseDNA, ProtozoanLaurenciaMitochondriaMitochondrial MembranesOxidative StressReactive Oxygen SpeciesSpiro CompoundsTrypanocidal AgentsTrypanosoma cruziVacuolesDNA, ProtozoanelatolReactive Oxygen SpeciesSpiro CompoundsTrypanocidal AgentsChagas’ disease(−)-elatolmitochondriaoxidative stressTrypanosoma cruzi

Identifiers

PMID23015766
PMCPMC3447331
OpenAlexW1978994127

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.